Celgene Regional Marketing Manager Multiple Myeloma in Detroit, Michigan
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Celgene is a global leader in hematology, with a market-leading multiple myeloma franchise and promising future pipeline. We seek a Regional Marketing Manager (RMM) for the Central Region. This position is an extension of the HQ MM Marketing Team.
Responsibilities will include, but are not limited to, the following:
Coordinate with cross-functional home office/ field teams to ensure aligned implementation of the brand strategy
Collaborate to pull-through national strategy at a regional/ local level
Understand emerging MM trends to drive the future national strategy- Learning Locally, Applying Nationally
Regional insight generation (quarterly) aligned with Regional Sales Directors and HQ Brand Team
Highlight local deviations from the Nation; gather input to understand the drivers of variation and synthesize the implications to the business into a Regional MM Assessment
Work closely with sales, market access and other relevant cross-functional experts to build a strategic understanding of regional and account level dynamics
Present quarterly and yearly business reviews, contributing to Brand Strategic and Tactical plans
Regional Planning (2x per year)
Translate Regional MM Assessment into prioritized opportunities aligned to National Brand Plans
Develop Regional Action plan- the tactical approach to address opportunities, including budget estimate and establish cross-functional accountability (excluding Medical)
Implementation and Enablement
Pull through National/ Regional Action plans and brand tactics
Monitor and assess impact of Regional Action Plan
Appropriately engaging with key stakeholders in the Hematology/Oncology customer accounts
Support the launch of new indication, including development and roll out of comprehensive launch plans
10 years of pharmaceutical industry or relevant experience
Must have direct people management experience with the ability lead others
The preferred candidate will have an oncology/hematology background with at least 6+ years of in-line experience in pharmaceutical marketing and/or sales/market access experience
Proven team player with ability to navigate and collaborate cross functionally
Must be self-motivated with the ability to think strategically, drive performance, foster relationships and build alignment via lateral leadership and influencing without authority
Strong project and process management skills, along with the ability to work on multiple tasks, and to effectively prioritize
Strong communications skills and track record of effective and influential presentations to external and internal customers
Bachelor’s degree required; MBA preferred
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.